These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16377270

  • 1. Potential predictive factors of osteoporosis in HIV-positive subjects.
    Fausto A, Bongiovanni M, Cicconi P, Menicagli L, Ligabò EV, Melzi S, Bini T, Sardanelli F, Cornalba G, Monforte Ad.
    Bone; 2006 Jun; 38(6):893-7. PubMed ID: 16377270
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 3. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2004 Mar 30; 48(1):39-48. PubMed ID: 15195003
    [Abstract] [Full Text] [Related]

  • 4. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men.
    Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC.
    J Med Virol; 2007 Oct 30; 79(10):1446-54. PubMed ID: 17705184
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, Davis TM.
    Diabet Med; 2009 Jan 30; 26(1):45-52. PubMed ID: 19125760
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM, Soori T, Kheirandish P, Izadyar S, SeyedAlinagh S, Foroughi M, Rostamian A, Mohraz M.
    Acta Med Iran; 2011 Jan 30; 49(7):460-7. PubMed ID: 21960080
    [Abstract] [Full Text] [Related]

  • 7. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.
    Clin Infect Dis; 2007 Oct 01; 45(7):925-32. PubMed ID: 17806063
    [Abstract] [Full Text] [Related]

  • 8. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S.
    Maturitas; 2008 Oct 01; 60(3-4):253-6. PubMed ID: 18778903
    [Abstract] [Full Text] [Related]

  • 9. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 10. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Mannazzu M, Falchi A, Sanna D, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2009 Jun 30; 53(3):290-301. PubMed ID: 18596668
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2007 Aug 30; 67(2):270-5. PubMed ID: 17547686
    [Abstract] [Full Text] [Related]

  • 12. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

  • 13. Sickle cell anaemia: is it a cause for secondary osteoporosis?
    Sadat-Ali M, Al Elq AH.
    West Afr J Med; 2007 Mar 20; 26(2):134-7. PubMed ID: 17939316
    [Abstract] [Full Text] [Related]

  • 14. Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
    Bongiovanni M, Gianotti N, Chiesa E, Nasta P, Cicconi P, Capetti A, di Biagio A, Matti A, Tirelli V, Marconi P, de Luca A, Mussini C, Gatti F, Zaccarelli M, Abeli C, Torti C, Antinori A, Castagna A, d'Arminio Monforte A.
    Infection; 2007 Dec 20; 35(6):451-6. PubMed ID: 18034204
    [Abstract] [Full Text] [Related]

  • 15. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 Dec 20; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
    Marcén R, Caballero C, Uriol O, Fernández A, Villafruela JJ, Pascual J, Martins J, Rodriguez N, Burgos FJ, Ortuño J.
    Transplant Proc; 2007 Sep 20; 39(7):2256-8. PubMed ID: 17889156
    [Abstract] [Full Text] [Related]

  • 17. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
    Clay PG, Voss LE, Williams C, Daume EC.
    Ann Pharmacother; 2008 May 20; 42(5):670-9. PubMed ID: 18413693
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and bone mineral densitiy in HIV-1-infected male subjects.
    Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG.
    Eur J Med Res; 2008 Apr 30; 13(4):173-8. PubMed ID: 18504173
    [Abstract] [Full Text] [Related]

  • 19. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL, Liang TB, Wu LH, Li DL, Geng L, Wang WL, Shen Y, Zhang M, Zheng SS.
    Transplant Proc; 2007 Dec 30; 39(10):3182-5. PubMed ID: 18089348
    [Abstract] [Full Text] [Related]

  • 20. The effect of measurement of the contralateral hip if the spine is not included in the bone mineral density analysis.
    Cole R, Larson J.
    J Clin Densitom; 2006 Dec 30; 9(2):210-6. PubMed ID: 16785083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.